• SENSEX
    NIFTY 50
Healthcare

Serum Institute gets approval to resume India trial of AstraZeneca COVID Vaccine

Updated : September 16, 2020 05:34 PM IST

Serum Institute gets approval to resume India trial of AstraZeneca COVID Vaccine

You May Also Like

Live TV
Advertisement